SteveGrenard
Philosopher
- Joined
- Oct 6, 2002
- Messages
- 5,528
Here is an important and realistic assessment of the problems associated with China's new industrial might, especially when it comes to pharmaceuticals and other products which are ingested. The asessment is well balanced by similar problems arising in other countries as well but focusses mainly on the situation in China. For China watchers it is worth reading.
http://www.nytimes.com/2008/11/02/magazine/02fda-t.html?hp=&pagewanted=all
The Safety Gap
http://www.nytimes.com/2008/11/02/magazine/02fda-t.html?hp=&pagewanted=all
The Safety Gap
The Safety Gap
By GARDINER HARRIS
Published: October 31, 2008
In the belly of an industrial district south of Lyon, France, just past a sulfurous oil refinery and a synthetic vanilla plant, sits a run-down, eight-story factory that makes aspirin, the first pharmaceutical blockbuster. The Lyon factory is the last of its kind. No other major facility in Europe or the United States makes generic aspirin anymore. The market has been taken over by low-cost Chinese producers. Even Bayer, the German company that created aspirin in the 1890s and has fought for more than a century to distinguish its product as the most trustworthy one, now has backup supplies from China.